Rydex Health Care Fund Class Investor
RYHIX
NASDAQ
Weiss Ratings | RYHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C | |||
Risk Index | Fair | |||
Risk Grade | C+ | |||
Company Info | RYHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | Rydex Funds | |||
Manager/Tenure (Years) | Michael P. Byrum (26), Adrian Bachman (2), Brendan Cain (2), 2 others | |||
Website | http://www.guggenheiminvestments.com | |||
Fund Information | RYHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | Rydex Health Care Fund Class Investor | |||
Category | Health | |||
Sub-Category | Healthcare Sector Equity | |||
Prospectus Objective | Specialty - Health | |||
Inception Date | Apr 17, 1998 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | 2,500.00 | |||
Minimum Subsequent Investment | -- | |||
Front End Fee | -- | |||
Back End Fee | -- | |||
Dividends and Shares | RYHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 0.00% | |||
Dividend | RYHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 1.24% | |||
Asset Allocation | RYHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | 0.46% | |||
Stock | 99.62% | |||
U.S. Stock | 94.09% | |||
Non-U.S. Stock | 5.53% | |||
Bond | 0.00% | |||
U.S. Bond | 0.00% | |||
Non-U.S. Bond | 0.00% | |||
Preferred | 0.00% | |||
Convertible | 0.00% | |||
Other Net | -0.08% | |||
Price History | RYHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -1.55% | |||
30-Day Total Return | -2.34% | |||
60-Day Total Return | 2.97% | |||
90-Day Total Return | -1.89% | |||
Year to Date Total Return | 4.25% | |||
1-Year Total Return | -0.03% | |||
2-Year Total Return | 11.36% | |||
3-Year Total Return | 8.05% | |||
5-Year Total Return | 45.25% | |||
Price | RYHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | -- | |||
1-Month Low Price | -- | |||
1-Month High Price | -- | |||
52-Week Low Price | -- | |||
52-Week Low Price (Date) | -- | |||
52-Week High Price | -- | |||
52-Week High Price (Date) | -- | |||
NAV | RYHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Nav | $128.26 | |||
1-Month Low NAV | $128.26 | |||
1-Month High NAV | $132.72 | |||
52-Week Low NAV | $121.86 | |||
52-Week Low NAV (Date) | Apr 18, 2024 | |||
52-Week High NAV | $137.43 | |||
52-Week High Price (Date) | Aug 30, 2024 | |||
Beta / Standard Deviation | RYHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.77 | |||
Standard Deviation | 15.46 | |||
Balance Sheet | RYHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 20.94M | |||
Operating Ratios | RYHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 1.40% | |||
Turnover Ratio | 116.00% | |||
Performance | RYHIX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 6.08% | |||
Last Bear Market Total Return | -10.70% | |||